Literature DB >> 11849398

Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells.

Sonja Mandl-Weber1, Clemens D Cohen, Bettina Haslinger, Matthias Kretzler, Thomas Sitter.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) was recently found in peritoneal effluents of peritoneal dialysis (PD) patients. It was suggested that human peritoneal mesothelial cells (HMC) contribute to the intraperitoneal production of VEGF, which may augment vascular permeability, vasodilation and neoangiogenesis in the peritoneal membrane. The present study was designed to assess the influence of proinflammatory cytokines, thrombin, d-glucose and glycated albumin in the regulation of VEGF synthesis in primary HMC cultures.
METHODS: VEGF antigen concentrations were measured in the cell supernatant by ELISA and VEGF mRNA expression was evaluated by real time RT-PCR.
RESULTS: Incubation of HMC with interleukin-1alpha (IL-1alpha; 10 to 100 U/mL), tumor necrosis factor-alpha (TNF-alpha; 500 to 1000 U/mL) or thrombin (1 to 10 U/mL) resulted in a time (24 to 72 hours) and concentration dependent increase in VEGF synthesis. In contrast, d-glucose (30 to 90 mmol/L), which is commonly used as an osmotic agent in peritoneal dialysis, was not able to up-regulate VEGF expression. High glucose levels even decreased VEGF production. However, exposure of HMC to Amadori-modified glycated albumin, which is generated in the peritoneal cavity in the presence of glucose-based dialysis solutions, resulted in a dose and time dependent increase in VEGF mRNA expression and antigen secretion.
CONCLUSIONS: These results demonstrate, to our knowledge for the first time, that glycated serum albumin, not glucose, increases VEGF production in HMC. HMC play an important role as a source of intraperitoneal VEGF synthesis, and VEGF expression also is up-regulated in the presence of proinflammatory cytokines and thrombin. Additionally, these results confirm clinical data that the continuous exposure of the peritoneal membrane to glucose-based dialysis solutions is an important stimulus for VEGF expression. However, it is not glucose per se, but nonenzymatic glycation products like glycated albumin that up-regulate VEGF expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849398     DOI: 10.1046/j.1523-1755.2002.00143.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  32 in total

Review 1.  Peritoneal damage by peritoneal dialysis solutions.

Authors:  Takafumi Ito; Noriaki Yorioka
Journal:  Clin Exp Nephrol       Date:  2008-02-15       Impact factor: 2.801

2.  Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.

Authors:  Susan Yung; Sing Leung Lui; Chris K F Ng; Andrew Yim; Maggie K M Ma; Kin Yee Lo; Chik Cheung Chow; Kwok Hong Chu; Wai Leung Chak; Man Fai Lam; Chun Yu Yung; Terence P S Yip; Sunny Wong; Colin S O Tang; Flora S K Ng; Tak Mao Chan
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

Review 3.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

4.  Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells.

Authors:  Julián Nevado; Concepción Peiró; Susana Vallejo; Mariam El-Assar; Nuria Lafuente; Nuria Matesanz; Verónica Azcutia; Elena Cercas; Carlos F Sánchez-Ferrer; Leocadio Rodríguez-Mañas
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

5.  Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis.

Authors:  Sibel Ada; Sibel Ersan; Aykut Sifil; Mehtat Unlu; Efsun Kolatan; Mehmet Sert; Sulen Sarioglu; Osman Yilmaz; Taner Camsari
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

Review 6.  An update on peritoneal dialysis solutions.

Authors:  Elvia García-López; Bengt Lindholm; Simon Davies
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

7.  Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats.

Authors:  Fengxin Zhu; Tang Li; Fanghua Qiu; Jinjin Fan; Qin Zhou; Xuebing Ding; Jing Nie; Xueqing Yu
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

8.  The effect of low-GDP solution on ultrafiltration and solute transport in continuous ambulatory peritoneal dialysis patients.

Authors:  Kyu-Hyang Cho; Jun-Young Do; Jong-Won Park; Kyung-Woo Yoon; Yong-Lim Kim
Journal:  Perit Dial Int       Date:  2013-01-02       Impact factor: 1.756

9.  Resident progenitors, not exogenous migratory cells, generate the majority of visceral mesothelium in organogenesis.

Authors:  Nichelle I Winters; Annabelle M Williams; David M Bader
Journal:  Dev Biol       Date:  2014-04-16       Impact factor: 3.582

10.  Disruption of the integrity of human peritoneal mesothelium by interleukin-1beta and tumor necrosis factor-alpha.

Authors:  Sylvia Stadlmann; Ruth Raffeiner; Albert Amberger; Raimund Margreiter; Alain Gustave Zeimet; Burkhardt Abendstein; Patrizia Lucia Moser; Gregor Mikuz; Bernd Klosterhalfen; Felix Albert Offner
Journal:  Virchows Arch       Date:  2003-07-26       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.